Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
Irazu Oncology has raised $250K in total funding. The most recent round was Undisclosed. The last funding was announced in July 2026.
Irazu Oncology's investors include TEDCO.
Irazu Oncology is headquartered in Baltimore, United States.
Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
Irazu Oncology is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Irazu Oncology — Funding & Investors." VCBacked, July 7, 2026, https://www.vcbacked.co/company/irazu-oncology. Accessed October 30, 2026.
VCBacked. (2026). Irazu Oncology — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/irazu-oncology
{{cite web |title=Irazu Oncology — Funding & Investors |url=https://www.vcbacked.co/company/irazu-oncology |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated